KRAS and rectal cancer: In patients with colon or sigmoid colon cancer, the SUVmax had a greater accuracy in predicting KRAS mutations, whereas in patients with rectal cancer, the accuracy of the SUVmax in predicting KRAS mutations was the same as that of TW40.